{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": [], "KeywordList": [], "GeneralNote": [], "PMID": "20228943", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1874-3900", "JournalIssue": {"Volume": "3", "Issue": "1", "PubDate": {"Year": "2010", "Month": "Mar", "Day": "12"}}, "Title": "Phytochemistry letters", "ISOAbbreviation": "Phytochem Lett"}, "ArticleTitle": "The continuing search for antitumor agents from higher plants.", "Pagination": {"StartPage": "1", "EndPage": "8", "MedlinePgn": "1-8"}, "Abstract": {"AbstractText": ["Plant secondary metabolites and their semi-synthetic derivatives continue to play an important role in anticancer drug therapy. In this short review, selected single chemical entity antineoplastic agents from higher plants that are currently in clinical trials as cancer chemotherapy drug candidates are described. These compounds are representative of a wide structural diversity. In addition, the approaches taken toward the discovery of anticancer agents from tropical plants in the laboratory of the authors are summarized. The successful clinical utilization of cancer chemotherapeutic agents from higher plants has been evident for about half a century, and, when considered with the promising pipeline of new plant-derived compounds now in clinical trials, this augurs well for the continuation of drug discovery research efforts to elucidate additional candidate substances of this type."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, OH 43210, USA."}], "Identifier": [], "LastName": "Pan", "ForeName": "Li", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chai", "ForeName": "Heebyung", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kinghorn", "ForeName": "A Douglas", "Initials": "AD"}], "GrantList": [{"GrantID": "P01 CA125066", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P01 CA125066-030001", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "U19 CA052956", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Phytochem Lett", "NlmUniqueID": "101513432", "ISSNLinking": "1874-3900"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Adams TE, El Sous M, Hawkins BC, Hirner S, Holloway G, Khoo ML, Owen DJ, Savage GP, Scammells PJ, Rizzacasa MA. Total synthesis of the potent anticancer Aglaia metabolites (-)-silvestrol and (-)-episilvestrol and the active analogue (-)-4\u2032-desmethoxyepisilvestrol. J. Am. Chem. Soc. 2009;131:1607\u20131616.", "ArticleIdList": ["19140688"]}, {"Citation": "Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 2007;595:1\u201375.", "ArticleIdList": ["17569205"]}, {"Citation": "Alakurtti S, M\u00e4kel\u00e4 T, Koskimies S, Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin. Eur. J. Pharm. Sci. 2006;29:1\u201313.", "ArticleIdList": ["16716572"]}, {"Citation": "American Cancer Society . Global Cancer Facts and Figures 2007. American Cancer Society; Atlanta: 2007."}, {"Citation": "Anonymous Assay development. Nat. Rev. Drug. Disc. 2007;6:681."}, {"Citation": "Bailey HH, Attia S, Love RR, Fass T, Chappell R, Tutsch K, Harris L, Jumonville A, Hansen R, Shapiro GR, Stewart JA. Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. Cancer Chemother. Pharmacol. 2008;62:149\u2013157.", "ArticleIdList": ["17885756"]}, {"Citation": "Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life. Sci. 2005;78:431\u2013441.", "ArticleIdList": ["16198377"]}, {"Citation": "Belanger JT. Perillyl alcohol : applications in oncology. Altern. Med. Rev. 1998;3:448\u2013457.", "ArticleIdList": ["9855569"]}, {"Citation": "Bindseil KU, Jakupovic J, Wolf D, Lavayre J, Leboul J, van der Pyl D. Pure compound libraries: a new perspective for natural product based drug discovery. Drug. Discov. Today. 2001;6:840\u2013847.", "ArticleIdList": ["11495757"]}, {"Citation": "Bordeleau ME, Robert F, Gerard B, Lindqvist L, Chen SMH, Wendel HG, Brem B, Greger H, Lowe SW, Porco JA, Jr., Pelletier JJ. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. Clin. Inv. 2008;118:1\u201311.", "ArticleIdList": ["PMC2423864", "18551192"]}, {"Citation": "Butler MS. Natural products to drugs: natural product-derived compounds in clinical trials. Nat. Prod. Rep. 2008;25:475\u2013516.", "ArticleIdList": ["18497896"]}, {"Citation": "Cai Y-J, Lu JJ, Zhu H, Xie H, Huang M, Lin LP, Zhang X-W, Ding J. Salvicine triggers DNA double-strand breaks and apoptosis by GSH-depletion-driven H2O2 generation and topoisomerase II inhibition. Free Radic. Biol. Med. 2008;45:627\u2013635.", "ArticleIdList": ["18582559"]}, {"Citation": "Cencic R, Carrier M, Galicia-V\u00e1zquez G, Bordeleau M-E, Sukarieh R, Bourdeau A, Brem B, Teodoro JG, Greger H, Tremblay ML, Porco JA, Jr., Pelletier J. Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. PLoS ONE. 2009;4(4):e5223.", "ArticleIdList": ["PMC2671147", "19401772"]}, {"Citation": "Chabner BA, Amrein PC, Druker BJ, Michaelson MD, Mitsiades CS, Gross PE, Ryan DP, Ramachandra S, Richardson PG, Supko JG, Wilson WH. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. Brunton LL, Laso JS, Parker KL, editors. McGraw-Hill; New York: 2005. pp. 1315\u20131403."}, {"Citation": "Chichewicz RH, Kouzi SA. Chemical, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med. Res. Rev. 2004;24:90\u2013114.", "ArticleIdList": ["14595673"]}, {"Citation": "Choueiri TK, Wesolowski R, Mekhail TM. Phenoxodiol: isoflavone analog with antineoplastic activity. Curr. Oncol. Rep. 2006;8:104\u2013107.", "ArticleIdList": ["16507219"]}, {"Citation": "ClinicalTrials.gov  Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer. 2009a.  [October 2009].  Further information available at:  http://clinicaltrials.gov/ct2/show/NCT00507429."}, {"Citation": "ClinicalTrials.gov  A Study to Assess the Effectiveness of the Combination of Carboplatin, Paclitaxel, Bevacizumab and Combretastatin (CA4P) in Patients With Chemotherapy Na\u00efve Lung Cancer. 2009b.  [October 2009].  Further information available at:  http://clinicaltrials.gov/ct2/show/NCT00653939."}, {"Citation": "Constantinou AI, Husband A. Phenoxodiol [2H-1-benzopyran-7-ol, 3-(4-hydroxyphenyl)], a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex. Anticancer Res. 2002;22:2581\u20132585.", "ArticleIdList": ["12529967"]}, {"Citation": "Cooperative Study Group of Phase III Clinical Trial on Meisoindigo Phase II clinical trial on meisoindigo in the treatment of chronic myelogenous leukemia. Zhonghua Xueyexue Zazhi. 1997;18:69\u201372.", "ArticleIdList": ["15622780"]}, {"Citation": "Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: Triumphs and trials. Cell. 2007;130:769\u2013774.", "ArticleIdList": ["PMC2507744", "17803898"]}, {"Citation": "Cragg GM, Boyd MR, Khanna R, Kneller R, Mays TD, Mazan KD, Newman DJ, Sausville EA. International collaboration in drug discovery and development: the NCI experience. Pure Appl. Chem. 1999;71:1619\u20131633."}, {"Citation": "Cragg GM, Kingston DGI, Newman DJ, editors. Anticancer Agents from Natural Products. CRC/Taylor & Francis; Boca Raton, FL: 2005."}, {"Citation": "Cragg GM, Newman DJ, Yang SS. Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J. Nat. Prod. 2006;69:488\u2013498.", "ArticleIdList": ["16562862"]}, {"Citation": "Cragg GM, Grothaus PG, Newman DJ. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 2009;109:3012\u20133043.", "ArticleIdList": ["19422222"]}, {"Citation": "Delmonte A, Sessa C. AVE8062: a new combretastatin derivative vascular disrupting agent. Expert. Opin. Investig. Drugs. 2009;18:1541\u20131548.", "ArticleIdList": ["19758109"]}, {"Citation": "Deng B. Direct colorimetric method for determination of indigo and indirubin in Qingdai. Zhong Cao Yao. 1986;17:163\u2013164."}, {"Citation": "DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. 8th ed. Lippincott-Williams & Wilkins; Philadelphia: 2008."}, {"Citation": "Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008;14:4491\u20134499.", "ArticleIdList": ["18628464"]}, {"Citation": "Eisenbrand G, Hippe F, Jakobs S, Muehlbeyer S. Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J. Cancer Res. Clin. Oncol. 2004;130:627\u2013635.", "ArticleIdList": ["15340840"]}, {"Citation": "El Sous M, Khoo ML, Holloway G, Owen D, Scammells PJ, Rizzacasa MA. Total synthesis of (-)-silvestrol and (-)-episilvestrol. Angew. Chem. Int. Ed. 2007;46:7835\u20137838.", "ArticleIdList": ["17823902"]}, {"Citation": "Eyberger AL, Dondapati R, Porter JR. Endophytic fungal isolates from Podophyllum peltatum produce podophyllotoxin. J. Nat. Prod. 2006;69:1121\u20131124.", "ArticleIdList": ["16933860"]}, {"Citation": "Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspec. 2001;109:69\u201375.", "ArticleIdList": ["PMC1240543", "11250806"]}, {"Citation": "Fidler JM, Li K, Chung C, Wei K, Ross JA, Gao M, Rosen GD. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Mol. Cancer Ther. 2003;2:855\u2013862.", "ArticleIdList": ["14555704"]}, {"Citation": "Fischbach MA, Walsh CT. Biochemistry: Directing biosynthesis. Science. 2006;314:603\u2013605.", "ArticleIdList": ["17068249"]}, {"Citation": "Firn RD, Jones CG. Natural products-a simple model to explain chemical diversity. Nat. Prod. Rep. 2003;20:382\u2013391.", "ArticleIdList": ["12964834"]}, {"Citation": "Gerard B, Cencic R, Pelletier J, Porco JA., Jr. Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Angew. Chem. Int. Ed. 2007;46:7831\u20137835.", "ArticleIdList": ["17806093"]}, {"Citation": "Hallock YF, Cragg GM. National Cooperative Drug Discovery Groups (NCDDGs): a successful model for public private partnerships in cancer drug discovery. Pharm. Biol. 2003;41(Suppl):78\u201391."}, {"Citation": "Hartwell JL. Plants Used against Cancer: a Survey. Quarterman; Lawrence, MA: 1982."}, {"Citation": "Hartwell JL, Schrecker AW. Components of podophyllin. V. The constitution of podophyllotoxin. J. Am. Chem. Soc. 1951;73:2909\u20132916."}, {"Citation": "Harvey AL. Natural products in drug discovery. Drug Discov. Today. 2008;13:894\u2013901.", "ArticleIdList": ["18691670"]}, {"Citation": "Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, Grever MR. Life Sci. 1995;57:131\u2013141.", "ArticleIdList": ["7603295"]}, {"Citation": "Hwang BY, Su BN, Chai H-B, Mi Q, Kardono LBS, Afriastini JJ, Riswan S, Santarsiero BD, Mesecar AD, Wild R, Fairchild CR, Vite GD, Rose WC, Farnsworth NR, Cordell GA, Pezzuto JM, Swanson SM, Kinghorn AD. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J. Org. Chem. 2004;69:3350\u20133358. ibid. 6156.", "ArticleIdList": ["15132542"]}, {"Citation": "Itokawa H, Wang X, Lee K-H. Homoharringtonine and related compounds. In: Cragg GM, Kingston DGI, Newman DJ, editors. Anticancer Agents from Natural Products. CRC/Taylor & Francis; Boca Raton, FL: 2005. pp. 47\u201370."}, {"Citation": "Kantarjian HM, Talpaz M, Santini V, Murgo A, Cheson B, O'Brien SM. Homoharringtonine: history, current research, and future direction. Cancer. 2001;92:1591\u2013605.", "ArticleIdList": ["11745238"]}, {"Citation": "Kim S, Salim AA, Swanson SM, Kinghorn AD. Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy. Anti-cancer Agents Med. Chem. 2006;6:319\u2013345.", "ArticleIdList": ["16842234"]}, {"Citation": "King ML, Chiang CC, Ling HC, Fukita E, Ochiai M, McPhail AT. X-ray crystal structure of rocaglamide, a novel antileukemic 1H-cyclopenta[b]benzofuran from Aglaia elliptifolia. J. Chem. Soc., Chem. Commun. 1982:1150\u20131151."}, {"Citation": "Kinghorn AD. Drug discovery from natural products. In: Lemke R, Williams DA, editors. Foye's Principles of Medicinal Chemistry. 6th Edn. Walters Kluwer/Lippincott Williams & Wilkins; Baltimore: 2008. pp. 12\u201325."}, {"Citation": "Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, Pezzuto JM, Udeani GO, Wani MC, Wall ME, Navarro HA, Kramer RA, Menendez AT, Fairchild CR, Lane KE, Forenza S, Vyas DM, Lam KS, Shu Y-Z. Novel strategies for the discovery of plant-derived anticancer agents. Pure Appl. Chem. 1999;71:611\u20131618."}, {"Citation": "Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, Swanson SM, Pezzuto JM, Wani MC, Wall ME, Oberlies NH, Kroll DJ, Kramer RA, Rose WC, Vite GD, Fairchild CR, Peterson RW, Wild R. Novel strategies for the discovery of plant-derived anticancer agents. Pharm. Biol. 2003;41(Suppl):53\u201367."}, {"Citation": "Kinghorn AD, Carcache-Blanco EJ, Chai H-B, Orjala J, Farnsworth NR, Soejarto DD, Oberlies NH, Wani MC, Kroll DJ, Pearce CJ, Swanson SM, Kramer RA, Rose WC, Fairchild CR, Emanuel S, Vite GD, Jarjoura D, Cope FO. Discovery of anticancer agents of diverse natural origin. Pure Appl. Chem. 2009;81:1051\u20131063.", "ArticleIdList": ["PMC2765058", "20046887"]}, {"Citation": "Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin. Cancer Res. 2002;8:2666\u20132674.", "ArticleIdList": ["12171899"]}, {"Citation": "Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nature Rev. Drug Discov. 2005;4:206\u2013220.", "ArticleIdList": ["15729362"]}, {"Citation": "Li G, Wang ZH, Sun YX, Liu K, Wang Z. Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells. Basic Clin. Pharmacol. Toxicol. 2006;98:588\u2013592.", "ArticleIdList": ["16700822"]}, {"Citation": "Li JH-W, Vederas JG. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009;325:161\u2013165.", "ArticleIdList": ["19589993"]}, {"Citation": "Liu GY, Bu X, Yan H, Jia WWG. 20S-Protopanaxadiol-induced programmed cell death in glioma cells through caspase-dependent and -independent pathways. J. Nat. Prod. 2007;70:259\u2013265.", "ArticleIdList": ["17261067"]}, {"Citation": "Lucas DM, Edwards RB, Lozanski G, West DA, Shin JD, Vargo MA, Davis ME, Rozewski DM, Johnson AJ, Su BN, Goettl VM, Heerema NA, Lin TS, Lehman A, Zhang XL, Jarjoura D, Newman DJ, Byrd JC, Kinghorn AD, Grever MR. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood. 2009;113:4656\u20134666.", "ArticleIdList": ["PMC2680369", "19190247"]}, {"Citation": "Luo CY, Tang JY, Wang YP. Homoharringtonine: a new treatment option for myeloid leukemia. Hematology. 2004;9:259\u2013270.", "ArticleIdList": ["15621733"]}, {"Citation": "Meng H, Yang C, Jin J, Zhou Y, Qian W. Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Leuk. Lymphoma. 2008;49:1954\u20131962.", "ArticleIdList": ["18949618"]}, {"Citation": "Meurer-Grimes BM, Yu J, Vairo GL. Therapeutic compounds and methods. 2004. U.S. Patent 6710075."}, {"Citation": "Mi Q, Pezzuto JM, Farnsworth NR, Wani MC, Kinghorn AD, Swanson SM. Use of the in vivo hollow fiber assay in natural products drug discovery. J. Nat. Prod. 2009;72:573\u2013580.", "ArticleIdList": ["PMC2765512", "19161316"]}, {"Citation": "Miao ZH, Tang T, Zhang YX, Zhang JS, Ding J. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells. Int. J. Cancer. 2003;106:108\u2013115.", "ArticleIdList": ["12794765"]}, {"Citation": "Mor G, Fu HH, Alvero AB. Phenoxodiol, a novel approach for the treatment of ovarian cancer. Curr. Opin. Investig. Drugs. 2006;7:542\u2013548.", "ArticleIdList": ["16784025"]}, {"Citation": "Newman DJ, Cragg GM. Developments and future trends in anticancer natural products drug discovery. In: Cragg GM, Kingston DGI, Newman DJ, editors. Anticancer Agents from Natural Products. CRC Taylor & Francis; Boca Raton, FL: 2005. pp. 553\u2013571."}, {"Citation": "Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461\u201377.", "ArticleIdList": ["17309302"]}, {"Citation": "Neuss N, Gorman M, Boaz HW, Cone NJ. Vinca alkaloids. XI. Structures of leurocristine and vincaleukoblastine. J. Am. Chem. Soc. 1962;84:1509\u20131510."}, {"Citation": "Noble RH, Cutts JH, Beer CH. Further biological activities of vincaleukoblastine \u2013 an alkaloid isolated from Vinca rosea (L.). Biochem. Pharmacol. 1958;1:347\u2013348."}, {"Citation": "PanaGin Pharmaceuticals, Inc.  2009.  [October 2009].  Further information available at  http://www.panagin.com."}, {"Citation": "Peffley DM, Sharma C, Hentosh P, Buechler RD. Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G interactions in human tumor cells. Arch. Biochem. Biophys. 2007;465:266\u2013273.", "ArticleIdList": ["17601486"]}, {"Citation": "Pettit GR, Cragg GM, Herald DL, Schmidt JM, Lohavanijaya P. Isolation and structure of combretastatin. Can. J. Chem. 1982;60:1374\u20131376."}, {"Citation": "Pettit GR, Singh SB, Niven ML, Hamel E, Schmidt JM. Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of tubulin assembly, derived from Combretum caffrum. J. Nat. Prod. 1987;50:119\u2013131.", "ArticleIdList": ["3598594"]}, {"Citation": "Pinney KG, Jelinek C, Edvardsen K, Chaplin DJ, Pettit GR. The discovery and development of the combretastatins. In: Cragg GM, Kingston DGI, Newman DJ, editors. Anticancer Agents from Natural Products. CRC Taylor & Francis; Boca Raton, FL: 2005. pp. 23\u201346."}, {"Citation": "Pisha E, Chai H, Lee I-S, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CWW, Fong HHS, Kinghorn AD, Brown DM, Wani MC, Wall ME, Heijken TE, Das Gupta TK, Pezzuto JM. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nature (Med.) 1995;1:1046\u20131051.", "ArticleIdList": ["7489361"]}, {"Citation": "Popovich DG, Kitts DD. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch. Biochem. Biophys. 2002;406:1\u20138.", "ArticleIdList": ["12234484"]}, {"Citation": "Potterat O, Hamburger M. Natural products in drug discovery \u2013 concepts and approaches for tracking bioactivity. Curr. Org. Chem. 2006;10:899\u2013920."}, {"Citation": "Powell RG, Weisleder D, Smith CR. Antitumor alkaloids from Cephalotaxus harringtonia: structure and activity. J. Pharm. Sci. 1972;61:1227\u20131230.", "ArticleIdList": ["5050371"]}, {"Citation": "Puri SC, Verma V, Amna T, Qazi GN, Spiteller M. An endophytic fungus from Nothapodytes foetida that produces camptothecin. J. Nat. Prod. 2005;68:1717\u20131719.", "ArticleIdList": ["16378360"]}, {"Citation": "Quintas-Cardama A, Kantarjian H, Garcia-Manero G, O'Brien S, Faderl S, Estrov Z, Giles F, Murgo A, Ladie N, Verstovsek S, Cortes J. Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy. Cancer. 2007;109:248\u2013255.", "ArticleIdList": ["17154172"]}, {"Citation": "Ramgolam V, Ang SG, Lai YH, Loh CS, Yap HK. Traditional Chinese medicines as immunosuppressive agents. Ann. Acad. Med. Singapore. 2000;29:11\u201316.", "ArticleIdList": ["10748958"]}, {"Citation": "Raynal NJ-M, Momparler L, Charbonneau M, Momparler RL. Antileukemic activity of genistein, a major isoflavone present in soy products. J. Nat. Prod. 2008;71:3\u20137.", "ArticleIdList": ["18163589"]}, {"Citation": "Sashidhara KV, White KN, Crews P. A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products. J. Nat. Prod. 2009;71:588\u2013603.", "ArticleIdList": ["PMC2837139", "19209899"]}, {"Citation": "Saklani A, Kutty SK. Plant-derived compounds in clinical trials. Drug Disc. Today. 2008;13:161\u2013171.", "ArticleIdList": ["18275914"]}, {"Citation": "Silasi D-A, Alvero AB, Rutherford TJ, Brown D, Mor G. Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs. Exp. Opin. Pharmacother. 2009;10:1059\u20131067.", "ArticleIdList": ["19364253"]}, {"Citation": "Singh S. From exotic spice to modern drug? Cell. 2007;130:765\u2013768.", "ArticleIdList": ["17803897"]}, {"Citation": "Sneader W. Drug Discovery: a History. John Wiley & Sons, Ltd.; Chichester, UK: 2005."}, {"Citation": "Suffness M, Douros J. Current status of the NCI plant and animal program. J. Nat. Prod. 1982;45:1\u201314.", "ArticleIdList": ["7069421"]}, {"Citation": "Svoboda GH, Neuss N, Gorman M. Alkaloids of Vinca rosea (Catharanthus roseus). V. Preparation and characterization of alkaloids. J. Am. Pharm. Soc., Sci. Ed. 1959;48:659\u2013666.", "ArticleIdList": ["13854990"]}, {"Citation": "Svoboda GH. Alkaloids of Vinca rosea (Catharanthus roseus). IX. Extraction and characterization of leurosidine and leurocristine. Lloydia. 1961;24:173\u2013178."}, {"Citation": "Tan GT, Gylenhaal C, Soejarto DD. Biodiversity as a source of anticancer drugs. Curr. Drug Targ. 2006;7:265\u2013277.", "ArticleIdList": ["16515527"]}, {"Citation": "The Rocky Mountain Blood and Marrow Transplant Program (RMBMTP)  Initial patients treated in multinational phase 2/3 study of ceflatonin 09-20-2006. 2009.  [October 2009].  Further information available at :  http://www.rockymountainbmt.com/news/Initial-Patients-Treated-in-Multinational-Phase-23-Study-of-Ceflatonin-4682.html."}, {"Citation": "U.S. National Institutes of Health  Evaluation of 20% betulinic acid ointment for treatment of dysplastic nevi (moderate to severe dysplasia) 2009.  [October 2009].  Further information available at:  http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=494341&version=HealthProfessional&protocolsearchid=3664931."}, {"Citation": "Vuorelaa P, Leinonenb M, Saikkuc P, Tammelaa P, Rauhad JP, Wennberge T, Vuorela H. Natural products in the process of finding new drug candidates. Curr. Med. Chem. 2004;11:1375\u20131389.", "ArticleIdList": ["15180572"]}, {"Citation": "Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 1971;93:2325\u20132327.", "ArticleIdList": ["5553076"]}, {"Citation": "Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AI, Sim GA. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Am. Chem. Soc. 1966;88:3888\u20133890."}, {"Citation": "Xu RS. Dan-Shen (Salvia miltiorrhiza) \u2013 its Biology and Applications. Science Press; Beijing: 1990."}, {"Citation": "Yeruva L, Pierre KJ, Elegbede A, Wang RC, Carper SW. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett. 2007;257:216\u2013226.", "ArticleIdList": ["17888568"]}, {"Citation": "Young SL, Chaplin DJ. Combretastatin A4 phosphate: background and current clinical status. Expert. Opin. Invest. Drugs. 2004;13:171\u20131182.", "ArticleIdList": ["15330748"]}, {"Citation": "Zhang J-S, Ding J, Tang Q-M, Li M, Zhao M, Lu L-J, Chen L-J, Yuan S-T. Synthesis and antitumor activity of novel diterpene quinone salvicine and the analogs. Bioorg. Med. Chem. Lett. 1999;9:2731\u20132736.", "ArticleIdList": ["10509925"]}, {"Citation": "Zhongyaoshijia  2009.  [October 2009].  Further information available at  http://www.zysj.com.cn/zhongyaocai/yaocai_q/qingdai.html#399."}, {"Citation": "Zuo M, Li Y, Wang H, Zhou J, Li H, Liu H, Liu H, Xin H, Zhang S, Chen X. The antitumor activity of meisoindigo against human colorectal cancer HT-29 cells in vitro and in vivo. J. Chemother. 2008;20:728\u2013733.", "ArticleIdList": ["19129071"]}]}], "History": [{"Year": "2010", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "17", "Hour": "6", "Minute": "1"}, {"Year": "2011", "Month": "3", "Day": "12"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20228943", "NIHMS164127", "PMC2836022", "10.1016/j.phytol.2009.11.005"]}}], "PubmedBookArticle": []}